Biotech

All Articles

iTeos- GSK's TIGIT superstar shows meaningful remodeling

.After declaring a period 3 launch based on good midstage outcomes, iTeos and also GSK are finally s...

More joint FDA may speed up unusual disease R&ampD: record

.The FDA ought to be actually much more open and collaborative to let loose a surge in commendations...

Zenas, MBX, Bicara head to Nasdaq in warm time for biotech IPOs

.It is actually an abnormally occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and ...

Atea's COVID antiviral neglects to stop hospitalizations in period 3

.Atea Pharmaceuticals' antiviral has actually stopped working yet another COVID-19 test, but the bio...

Neurocrine's offer to save mental illness possibility stops working

.Neurocrine Biosciences' schizophrenia system pivot has actually stopped working. The biotech was in...

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has brought in a late entrance to the radioligand celebration, paying 100 million europeans ...

F 2G rears $100M for 2nd attempt to acquire brand-new antifungal to market

.After F2G's very first attempt to acquire a new course of antifungal to market was wrecked by the F...

Moderna targets $1.1 B in R&ampD investing cuts, drops 5 courses amid success stress

.Moderna has promised to reduce R&ampD investing by $1.1 billion by 2027. The selection to shrink th...

Sanofi's $80M bet on Key dystrophy medicine ends in period 3 go belly up

.Simply 4 months after Sanofi bet $80 million in upfront cash on Pivot Therapeutics' losmapimod, the...

Oncternal share sinks 60% amid layoffs, test firings

.Cancer company Oncternal Therapeutics is folding all its own scientific tests as well as laying off...